FCR vs. BR - Is One Better?
Jennifer Brown, MD, discusses the choice in chemoimmunotherapy, FCR (fludarabine, cyclophosphamide and rituximab) vs BR. FCR has been the standard the...
GRACEcast
Share:
Listens: 20
About
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit CancerGRACE.org for more info.
New Trials of Targeting Therapies to Treat Leptomeningeal Carcinomatosis
GRACE is happy to present the 8th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer. Featuring Jack West, ...
ASCO 2016 LC RT Vid 8 - Promising Early Results for Treatments
GRACE is happy to present the 8th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer. Featuring Jack West, ...
Immuno-oncology Developments - Combinations and Use as First-Line Therapy
GRACE is happy to present the 6th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer. Featuring Jack West, ...
Does Current Evidence Support Favoring Proton-Beam Radiation
GRACE is happy to present the 6th video in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer. Featuring Jack ...
J-Alex Trial: Should Alecensa Replace Xalkori as First-Line ALK Therapy?
GRACE is happy to present the 5th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer. Featuring Jack West, ...
Are There Less Toxic Alternatives to the Extreme Regimen
GRACE is happy to present the 9th video in our series ASCO 2016 Head and Neck Roundtable, Treating Head and Neck Cancer. Featuring Jared Weiss, MD, J...